These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 1359295)

  • 21. Time scales of CD4+ T cell depletion in HIV infection.
    De Boer RJ
    PLoS Med; 2007 May; 4(5):e193. PubMed ID: 17518517
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dynamics of HIV-1 and CD4+ lymphocytes in vivo.
    Perelson AS; Essunger P; Ho DD
    AIDS; 1997; 11 Suppl A():S17-24. PubMed ID: 9451962
    [No Abstract]   [Full Text] [Related]  

  • 23. HIV Susceptibility of human antigen-specific CD4 T cells in AIDS pathogenesis and vaccine response.
    Hu H; Liu F; Kim J; Ratto-Kim S
    Expert Rev Vaccines; 2016 Jun; 15(6):709-17. PubMed ID: 26814372
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of host immunity in the control of HIV infection: from theory to diagnostic and therapeutic intervention.
    Lazzarin A
    New Microbiol; 2004 Apr; 27(2 Suppl 1):135-9. PubMed ID: 15646077
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immune activation and the pathogenesis of HIV disease: implications for therapy.
    Fernandez S; Lim A; French M
    J HIV Ther; 2009 Nov; 14(3):52-6. PubMed ID: 20218239
    [No Abstract]   [Full Text] [Related]  

  • 26. GM-CSF production by CD4+ T-lymphocytes is selectively impaired during the course of HIV-1 infection. A possible indication of a preferential lesion of a specific subset of peripheral blood CD4+ T-lymphocytes.
    Re MC; Zauli G; Furlini G; Giovannini M; Ranieri S; Ramazzotti E; Vignoli M; La Placa M
    Microbiologica; 1992 Jul; 15(3):265-70. PubMed ID: 1354325
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The immunopathology of HIV infection.
    Andrews CA; Koup RA
    J Antimicrob Chemother; 1996 May; 37 Suppl B():13-25. PubMed ID: 8818826
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Functional impairment of CD4 T cells despite normalization of T cell number in HIV.
    Knox KS; Day RB; Kohli LM; Hage CA; Twigg HL
    Cell Immunol; 2006 Jul; 242(1):46-51. PubMed ID: 17070790
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Uncovering HIV-1-infected cells.
    Veillette M; Richard J; Finzi A
    Oncotarget; 2015 Sep; 6(26):21791-2. PubMed ID: 26314853
    [No Abstract]   [Full Text] [Related]  

  • 30. [Does HIV stimulate T-lymphocytes to "suicide"?].
    Fortschr Med; 1992 Apr; 110(12):18-9. PubMed ID: 1351024
    [No Abstract]   [Full Text] [Related]  

  • 31. Pathogenesis puzzle.
    Simmons P
    Res Initiat Treat Action; 1999 Oct; 5(4):13-4. PubMed ID: 11366937
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Progress in immunologic therapy approaches. Vitalizing HIV immune defenses].
    MMW Fortschr Med; 2001 Apr; 143 Suppl 1():99. PubMed ID: 11373797
    [No Abstract]   [Full Text] [Related]  

  • 33. Mucosal immunodeficiency in HIV/SIV infection.
    Zeitz M; Ullrich R; Schneider T; Kewenig S; Riecken E
    Pathobiology; 1998; 66(3-4):151-7. PubMed ID: 9693317
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Fas receptor in HIV infection: expression on peripheral blood lymphocytes and role in the depletion of T cells.
    Gehri R; Hahn S; Rothen M; Steuerwald M; Nuesch R; Erb P
    AIDS; 1996 Jan; 10(1):9-16. PubMed ID: 8924258
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Immunobiology of HIV infection].
    Hattori T
    Uirusu; 2002 Dec; 52(2):245-9. PubMed ID: 12685315
    [No Abstract]   [Full Text] [Related]  

  • 36. Gut-homing α4β7 CD4+ T cells: potential key players in both acute HIV infection and HIV-associated cancers.
    Wang Y; Lu X; Wu H; Li W
    Cell Mol Immunol; 2018 Feb; 15(2):190-192. PubMed ID: 29082921
    [No Abstract]   [Full Text] [Related]  

  • 37. HIV, HTLV-I, and CD4+ lymphocytes. Troubles in the relationship.
    Volberding PA
    JAMA; 1994 Feb; 271(5):392-3. PubMed ID: 7904318
    [No Abstract]   [Full Text] [Related]  

  • 38. Dominant enrichment of phenotypically activated CD38(+) HLA-DR(+) CD8(+) T cells, rather than CD38(+) HLA-DR(+) CD4(+) T cells, in HIV/HCV coinfected patients on antiretroviral therapy.
    d'Ettorre G; Ceccarelli G; Serafino S; Giustini N; Cavallari EN; Bianchi L; Pavone P; Bellelli V; Turriziani O; Antonelli G; Stroffolini T; Vullo V
    J Med Virol; 2016 Aug; 88(8):1347-56. PubMed ID: 26765625
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modelling the influence of activation-induced apoptosis of CD4+ and CD8+ T-cells on the immune system response of a HIV-infected patient.
    Stan GB; Belmudes F; Fonteneau R; Zeggwagh F; Lefebvre MA; Michelet C; Ernst D
    IET Syst Biol; 2008 Mar; 2(2):94-102. PubMed ID: 18397120
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Patients benefit from using own CD4 T-cells.
    AIDS Alert; 2002 Apr; 17(4):48-9. PubMed ID: 12030201
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.